The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells
The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells
复制标题
DOI:
10.1097/cad.0000000000000668
复制
发表时间:
2018-11-01
影响因子:
2.3
通讯作者:
Atashi, Amir
中科院分区:
文献类型:
--
作者:
Kazemi, Alireza;Sadri, Mohammadreza;Atashi, Amir
Although recent studies have reported different aspects of autophagy, from pro-survival to pro-death roles of this process in malignant cells, the underlying mechanisms by which autophagy inhibitors contribute toward the induction of programmed cell death in cancerous cells are still unclear. In the present study, we have attempted to explore some of the molecular features of pharmacological inhibition of autophagy in TF-1 cells (an acute erythroid leukemia model). Our findings indicated that ara-C induces autophagy (with alteration of LC3B, p62, and Beclin-1) in the cells; however, targeting autophagy by 3-methyladenine and chloroquine significantly increased caspase-dependent apoptosis and the sub-G(1) compartment in ara-C-treated cells. Moreover, cell cycle analysis showed that 3-MA, as an early-stage autophagy inhibitor, could elevate the cell population in the G(0)/G(1) cell cycle phase, which was associated with upregulation of p21 and p27 expressions. Interestingly, autophagy inhibition was also accompanied by downregulation of c-Myc gene and protein expression levels and upregulated levels of Bax and Bak gene expressions. In addition, following inhibition of autophagy, the levels of tumor-suppressive miRNA (i.e. miR-204) increased, whereas the values of oncogenic miRNAs (including miR-21, miR-221, miR-30a, and miR-17) decreased. Overall, our experiments indicate that autophagy inhibitors (especially chloroquine) seem to be promising agents for combination therapy in acute erythroid leukemia. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.